Management of pancreatogenic diabetes: challenges and solutions

References

• World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus Geneva World Health Organization 1999 [cited May 5, 2016]. Available from: http://apps.who.int/iris/bitstream/10665/66040/1/WHO_NCD_NCS_99.2.pdf Accessed May 5, 2016
   Google Scholar
• American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 2014 37 Suppl 1 S81 S90 24357215
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Standards of medical care in diabetes 2016 Diabetes Care 2016 39 Suppl 1 S1 S112 26696671
   PubMed Web of Science ®Google Scholar
• Ewald N Kaufmann C Raspe A Kloer HU Bretzel RG Hardt PD Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c) Diabetes Metab Res Rev 2012 28 4 338 342 22121010
   PubMed Web of Science ®Google Scholar
• Cui Y Andersen DK Pancreatogenic diabetes: special considerations for management Pancreatology 2011 11 3 279 294 21757968
   PubMed Web of Science ®Google Scholar
• Ewald N Bretzel RG Diabetes mellitus secondary to pancreatic diseases (Type 3c) - are we neglecting an important disease? Eur J Intern Med 2013 24 3 203 206 23375619
   PubMed Web of Science ®Google Scholar
• Hardt PD Brendel MD Kloer HU Bretzel RG Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care 2008 31 Suppl 2 S165 S169 18227480
   PubMed Web of Science ®Google Scholar
• Andersen DK The practical importance of recognizing pancreatogenic or type 3c diabetes Diabetes Metab Res Rev 2012 28 4 326 328 22279014
   PubMed Web of Science ®Google Scholar
• Gudipaty L Rickels MR Pancreatogenic (type 3c) diabetes Pancreapedia: Exocrine Pancreas Knowledge Base 2015 [cited May 5, 2016]. Available from: http://www.pancreapedia.org/sites/www.pancreapedia.org/files/DOI%20V3.%20formatted%20Type%203c%20DM%20chapter%208-13-15.pdf Accessed May 5, 2016
   Google Scholar
• Balzano G Dugnani E Pasquale V Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients Acta Diabetol 2014 51 5 801 811 24974302
   PubMed Web of Science ®Google Scholar
• Couet C Genton P Pointel JP The prevalence of retinopathy is similar in diabetes mellitus secondary to chronic pancreatitis with or without pancreatectomy and in idiopathic diabetes mellitus Diabetes Care 1985 8 4 323 328 4042797
   PubMed Web of Science ®Google Scholar
• Wang W Guo Y Liao ZA Occurrence of and risk factors for diabetes mellitus in Chinese patients with chronic pancreatitis Pancreas 2011 40 2 206 212 21404458
   PubMed Web of Science ®Google Scholar
• Moran A Brunzell C Cohen RC Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society Diabetes Care 2010 33 12 2697 2708 21115772
   PubMed Web of Science ®Google Scholar
• Rickels MR Bellin M Toledo FGS Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012 Pancreatology 2013 13 4 336 342 23890130
   PubMed Web of Science ®Google Scholar
• Magruder JT Elahi D Andersen DK Diabetes and pancreatic cancer: chicken or egg? Pancreas 2011 40 3 339 351 21412116
   PubMed Web of Science ®Google Scholar
• Whitcomb D Chronic pancreatitis, type 3c diabetes, and pancreatic cancer risk JOP 2014 15 5 2773
   Google Scholar
• Yasuda H Harano Y Ohgaku S Insulin sensitivity in pancreatitis, liver-diseases, steroid treatment and hyperthyroidism assessed by glucose, insulin and somatostatin infusion Horm Metab Res 1984 16 1 3 6 6141989
   PubMed Web of Science ®Google Scholar
• Yki-Jarvinen H Kiviluoto T Taskinen MR Insulin resistance is a prominent feature of patients with pancreatogenic diabetes Metabolism 1986 35 8 718 727 3736412
   PubMed Web of Science ®Google Scholar
• Nathan JD Zdankiewicz PD Wang J Impaired hepatocyte glucose transport protein (GLUT2) internalization in chronic pancreatitis Pancreas 2001 22 2 172 178 11249072
   PubMed Web of Science ®Google Scholar
• Tiengo A Vigili de Kreutzenberg S Del Prato S Diabetes in pancreatitis, pancreatectomy and other pancreatic diseases Ghigo E Porta M Diabetes Secondary to Endocrine and Pancreatic Disorders Front Diabetes 22 Basel Karger 2014 119 143
   Google Scholar
• Cui Y Andersen DK Diabetes and pancreatic cancer Endocr Relat Cancer 2012 19 5 F9 F26 22843556
   PubMed Web of Science ®Google Scholar
• Ebert R Creutzfeldt W Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution Diabetologia 1980 19 3 198 204 6997121
   PubMed Web of Science ®Google Scholar
• Knop FK Incretin hormones and beta cell function in chronic pancreatitis Dan Med Bull 2010 57 7 B4163 20591345
   PubMedGoogle Scholar
• Knop FK Vilsboll T Larsen S Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution Am J Physiol Endocrinol Metab 2007 292 1 E324 E330 16954337
   PubMed Web of Science ®Google Scholar
• Sikkens ECM Cahen DL Koch AD The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis Pancreatology 2013 13 3 238 242 23719594
   PubMed Web of Science ®Google Scholar
• Duggan SN O’Sullivan M Hamilton S Feehan SM Ridgway PF Conlon KC Patients with chronic pancreatitis are at increased risk for osteoporosis Pancreas 2012 41 7 1119 1124 22836855
   PubMed Web of Science ®Google Scholar
• Li D Yeung SC Hassan MM Konopleva M Abbruzzese JL Anti-diabetic therapies affect risk of pancreatic cancer Gastroenterology 2009 137 2 482 488 19375425
   PubMed Web of Science ®Google Scholar
• Libby G Donnelly LA Donnan PT Alessi DR Morris AD Evans JM New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes Diabetes Care 2009 32 9 1620 1625 19564453
   PubMed Web of Science ®Google Scholar
• Sadeghi N Abbruzzese JL Yeung SC Hassan M Li D Metformin use is associated with better survival of diabetic patients with pancreatic cancer Clin Cancer Res 2012 18 10 2905 2912 22465831
   PubMed Web of Science ®Google Scholar
• Kung J Henry RR Thiazolidinedione safety Expert Opinion Drug Saf 2012 11 4 565 579
   PubMed Web of Science ®Google Scholar
• Bowker SL Majumdar SR Veugelers P Johnson JA Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes Care 2006 29 2 254 258 16443869
   PubMed Web of Science ®Google Scholar
• Elashoff M Matveyenko AV Gier B Elashoff R Butler PC Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies Gastroenterology 2011 141 1 150 156 21334333
   PubMed Web of Science ®Google Scholar
• Iyer SN Tanenberg RJ Mendez CE Lee West R Drake AJIII Pancreatitis associated with incretin-based therapies Diabetes Care 2013 36 4 E49 23520376
   PubMed Web of Science ®Google Scholar
• Larsen PJ Mechanisms behind GLP-1 induced weight loss Br J Diabetes Vasc Dis 2008 8 Suppl 2 S34 S41
   Google Scholar
• Cefalu WT Riddle MC SGLT2 inhibitors: the latest “new kids on the block”! Diabetes Care 2015 38 3 352 354 25715412
   PubMed Web of Science ®Google Scholar
• Meier JJ Giese A Diabetes associated with pancreatic diseases Curr Opin Gastroenterol 2015 31 5 400 406 26125315
   PubMed Web of Science ®Google Scholar
• Rolon MA Benali K Munck A Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy Acta Paediatr 2001 90 8 860 867 11529531
   PubMed Web of Science ®Google Scholar
• Lanng S Thorsteinsson B Nerup J Koch C Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections Acta Paediatr 1994 83 8 849 853 7981562
   PubMed Web of Science ®Google Scholar
• Mozzillo E Franzese A Valerio G One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements Pediatr Diabetes 2009 10 3 162 167 19207231
   PubMed Web of Science ®Google Scholar
• Mohan K Israel KL Miller H Grainger R Ledson MJ Walshaw MJ Long-term effect of insulin treatment in cystic fibrosis related diabetes Respiration 2008 76 2 181 186 17960051
   PubMed Web of Science ®Google Scholar
• Hardin DS Rice J Rice M Rosenblatt R Use of the insulin pump to treat cystic fibrosis-related diabetes J Cyst Fibros 2009 8 3 174 178 19162566
   PubMed Web of Science ®Google Scholar
• Moran A Dunitz J Nathan B Saeed A Holme B Thomas W Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality Diabetes Care 2009 32 9 1626 1631 19542209
   PubMed Web of Science ®Google Scholar
• Larsen S Hilsted J Tronier B Worning H Pancreatic hormone secretion in chronic pancreatitis without residual beta-cell function Acta Endocrinol (Copenh) 1988 118 3 357 364 2899369
   PubMedGoogle Scholar
• Bellin MD Freeman ML Gelrud A Total pancreatectomy and islet autotransplantation in chronic pancreatitis: Recommendations from PancreasFest Pancreatology 2014 14 1 27 35 24555976
   PubMed Web of Science ®Google Scholar
• Grigore C Sarbu V Simion S Simion I Poteca T Nedelea S Pancreatogenic diabetes patient selection for pancreatic islet transplantation J Med Life 2010 3 1 84 89 20302203
   PubMedGoogle Scholar
• Sun YS Brunicardi FC Druck P Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide Am J Surg 1986 151 1 130 140 3946744
   PubMed Web of Science ®Google Scholar
• Brunicardi FC Chaiken RL Ryan AS Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis J Clin Endocrinol Metab 1996 81 10 3566 3572 8855802
   PubMed Web of Science ®Google Scholar
• Maeda H Hanazaki K Pancreatogenic diabetes after pancreatic resection Pancreatology 2011 11 2 268 276 21734430
   PubMed Web of Science ®Google Scholar
• Rabiee A Galiatsatos P Salas-Carrillo R Thompson MJ Andersen DK Elahi D Pancreatic polypeptide administration enhances insulin sensitivity and reduces the insulin requirement of patients on insulin pump therapy J Diabetes Sci Technol 2011 5 6 1521 1528 22226275
   PubMedGoogle Scholar
• Hennig R Kekis PB Friess H Adrian TE Buchler MW Pancreatic polypeptide in pancreatitis Peptides 2002 23 2 331 338 11825647
   PubMed Web of Science ®Google Scholar
• Andersen DK Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis Pancreas 2007 35 1 1 15 17575539
   PubMed Web of Science ®Google Scholar
• Andersen DK Andren-Sandberg Å Duell EJ Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop Pancreas 2013 42 8 1227 1237 24152948
   PubMed Web of Science ®Google Scholar
• Banerjee A Onyuksel H A novel peptide nanomedicine for treatment of pancreatogenic diabetes Nanomedicine 2013 9 6 722 728 23347897
   PubMed Web of Science ®Google Scholar